Showing results (21-30 of 58) with videos related to
Sort By:
Pageof 6
European Journal of Pediatrics|October 1, 2011
Health-related quality of life of pediatric patients with moderate to severe plaque psoriasis: comparisons to four common chronic diseasesJames W Varni, Denise R Globe, Shravanthi R Gandra, et al.Arthritis Care & Research|April 5, 2013
Impact of etanercept on work and activity impairment in employed moderate to severe rheumatoid arthritis patients in the United StatesDevon Hone, Annie Cheng, Crystal Watson, et al.BMC Health Services Research|June 25, 2015
Productivity loss and indirect costs associated with cardiovascular events and related clinical proceduresXue Song, Ruben G W Quek, Shravanthi R Gandra, et al.Journal of Medical Economics|November 26, 2011
Annual costs of tumor necrosis factor inhibitors using real-world data in a commercially insured population in the United StatesVernon F Schabert, Crystal Watson, Shravanthi R Gandra, et al.BMC Cardiovascular Disorders|January 16, 2016
Clinical and economic burden associated with cardiovascular events among patients with hyperlipidemia: a retrospective cohort studyKathleen M Fox, Li Wang, Shravanthi R Gandra, et al.Advances in Therapy|June 7, 2013
Tumor necrosis factor-blocker dose escalation in rheumatoid arthritis patients in a pharmacy benefit management settingSteven W Blume, Kathleen M Fox, George Joseph, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 25, 2009
Impact of erythropoiesis-stimulating agents on energy and physical function in nondialysis CKD patients with anemia: a systematic reviewShravanthi R Gandra, Fredric O Finkelstein, Antonia V Bennett, et al.Journal of Clinical Lipidology|February 20, 2016
Assessment of statin therapy, LDL-C levels, and cardiovascular events among high-risk patients in the United StatesSudhir K Unni, Ruben G W Quek, Joseph Biskupiak, et al.BMJ Open Diabetes Research & Care|October 6, 2015
Lipid-lowering treatment patterns among patients with type 2 diabetes mellitus with high cardiovascular disease riskRuben G W Quek, Kathleen M Fox, Li Wang, et al.Future Oncology (London, England)|October 7, 2024
Healthcare resource utilization and costs of chronic lymphocytic leukemia/small lymphocytic lymphoma patients who relapse or are refractory to ibrutinibEnrico De Nigris, Xiaoqin Yang, Enrico Zanardo, et al.Pageof 6